Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01720472 · ClinicalTrials.gov registry record
Implementing a Physical and Cognitive Performance Assessment Cohort in the MURDOCK Study Community Registry and Biorepository
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 1,000
- Enrollment target
NCT01720472: Completed study, sponsored by Duke University.
NCT01720472 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 1,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01720472 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
The purpose of this study is to use the MURDOCK Horizon 1.5 infrastructure (Duke Instutional Review Board Pro00011196) to specifically target and enroll 1,000 participants across age groups and other demographic categories in order to develop a diverse cohort with specific physical and cognitive performance data paired with biological samples.
Primary Outcome
Factors associated with physical function and physical activity and change in physical activity and function over two-year follow-up.
Interventions
- GENETIC Biomarker studies
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2012-05 |
| Est. Completion | 2018-08-28 |
What the finished NCT01720472 record still lists
NCT01720472 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Biomarker studies is the first listed.
NCT01720472 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01720472 about?
NCT01720472 is a clinical study titled "Implementing a Physical and Cognitive Performance Assessment Cohort in the MURDOCK Study Community Registry and Biorepository". The purpose of this study is to use the MURDOCK Horizon 1.5 infrastructure (Duke Instutional Review Board Pro00011196) to specifically target and enroll 1,000 participants across age groups and other demographic categories in order to develop a diverse cohort with specific physical and cognitive per...
What is the current status of trial NCT01720472?
This trial is currently completed. The enrollment target is 1,000 participants. The study started on 2012-05. Estimated completion is 2018-08-28.
What interventions are being tested in trial NCT01720472?
The interventions under investigation include: Biomarker studies (GENETIC).
Who is sponsoring clinical trial NCT01720472?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia